JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on June 6, 2006; DOI: 10.1124/jpet.106.104109


0022-3565/06/3183-1230-1239$20.00
JPET 318:1230-1239, 2006
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.106.104109v1
318/3/1230    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Martin, B. R.
Right arrow Articles by Razdan, R. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Martin, B. R.
Right arrow Articles by Razdan, R. K.

NEUROPHARMACOLOGY

Pharmacological Characterization of Novel Water-Soluble Cannabinoids

Billy R. Martin, Jenny L. Wiley, Irina Beletskaya, Laura J. Sim-Selley, Forrest L. Smith, William L. Dewey, Jean Cottney, Julia Adams, James Baker, David Hill, Bijali Saha, John Zerkowski, Anu Mahadevan, and Raj K. Razdan

Department of Pharmacology and Toxicology, Virginia Commonwealth University, Richmond, Virginia (B.R.M., J.L.W., I.B., L.J.S.-S., F.L.S., W.L.D.); Organon Laboratories, Ltd., Newhouse Industrial Estate, Lanarkshire, United Kingdom (J.C., J.A., J.B., D.H.); and Organix, Inc., Woburn, Massachusetts (B.S., J.Z., A.M., R.K.R.)

Presently, there are numerous structural classes of cannabinoid receptor agonists, all of which require solubilization for experimental purposes. One strategy for solubilizing water-insoluble tetrahydrocannabinols is conversion of the phenolic hydroxyl to a morpholinobutyryloxy substituent. The hydrochloride salts of these analogs are water-soluble and active in vivo when administered in saline. The present investigation demonstrated that hydrochloride salts of numerous substituted butyryloxy esters are water-soluble and highly potent. The substitutions include piperidine, piperazine, and alkyl-substituted amino moieties. It was also discovered that incorporation of a nitrogenous moiety in the alkyl side chain increased the pharmacological potency of tetrahydrocannabinol. For example, an analog containing a pyrazole in the side chain (O-2545) was found to have high affinity and efficacy at cannabinoid 1 (CB1) and CB2 receptors, and when dissolved in saline, it was highly efficacious when administered either intravenously or intracerebroventricularly to mice. A series of carboxamido and carboxylic acid amide analogs exhibited high pharmacological potency, but their hydrochloride salts were not water-soluble. On the other hand, incorporation of imidazoles into the terminus of the side chain led to water-soluble hydrochloride salts that were highly potent when administered in saline to laboratory animals. It is now possible to conduct cannabinoid research with agonists that are water-soluble and thus obviating the need of solubilizing agents.


Received April 18, 2006; accepted June 2, 2006.

Address correspondence to: Dr. Billy R. Martin, Department of Pharmacology and Toxicology, Virginia Commonwealth University, Box 980613, Richmond, VA 23298-0613. E-mail: martinb{at}hsc.vcu.edu







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2006 by the American Society for Pharmacology and Experimental Therapeutics.